Excellent review of how tagraxofusp has changed the face of a difficult disease. Great work by Naveen Pemmaraju, MD and colleagues!

Happy to see our 1st study of vaccine response in patients w MPN out eJHaem Journal. Grateful to a wonderful collaborative team: Petra Bachanova, Joan How, Richard Dzeng, Sonia Mukherjee, Maia Pavlovic, Jenn Lombardi, & @gabyhobbs More to come. onlinelibrary.wiley.com/doi/10.1002/jh…

Thrilled to see this in print! Great collaboration with Joan How Patrick Reeves Immune profiling responses to influenza vaccination in patients with MPN - onlinelibrary.wiley.com/doi/10.1002/jh…

I might never get invited back to ASH HQ after conducting all interviews on this very balcony today, but at least I witnessed a cosmic event with this extraordinary group of humans. Gaby Hobbs Diego Adrianzen-Herrera, MD Melody Smith, MD, MS

So honored that #ASH pASHions chose to highlight my love of running! There are so many reasons to run but Amy Comander MD, DipABLM, Anna Farago, MD, PhD, Nancy Lange-Vaidya and my other running buddies are such a gift - they inspire me and motivate me w every run!

Excited to share our new review in Reviews in Cardiovascular Medicine. Cardiotox in cancer #cardioonc pts is usually assoc w/ LV dysfunx, however cancer tx can affect the RV #ThePeoplesVentricle . We review incidence and management of PH/RV dysfunction. Eric H Yang, MD Manyoo
imrpress.com/journal/RCM/25…

Thank you Boston.com for sharing my story! I can't wait to run my 11th consecutive #BostonMarathon in just 6 weeks to honor Lynne & support the Ellie Fund. In the words of Amby Burfoot, “Every mile out there is a gift and every finish line is a gift.”

boston.com/community/bost…

Learn about the latest #myelofibrosis treatment and research on March 21st at 1pm ET with Gaby Hobbs of Mass General Cancer Center. Register here: ow.ly/e19150QK0xY #mpnsm #bloodcancer

We need more of this in the news- small changes in meat consumption are good for you and the planet- Swapping red meat for plant-based protein boosts longevity and climate health : Shots - Health News

npr.org/sections/healt…

Thank you Heme Today for the opportunity to discuss the results of this trial. Rux before, during and after HCT = less GVHD and excellent 1 year OS.

An Op-Ed I wrote for OBR Oncology on #RareDiseaseDay re: the time we ask of AYAs w/ sarcoma + musings/ideas on how we can reduce the time toxicity of our cancer treatments #AYACSM @DanaFarberNew obroncology.com/article/we-mus…

Thank you to Healio Women in Oncology for this interview, where I share my WHY for running #BostonMarathon #11 for the Ellie Fund in <7 weeks! In the words of des_linden, 'Remember, your WHY. When things get hard, you have the decision to bail or you can remember your why.'

WATCH: Experts discuss several recent data updates in polycythemia vera and myelofibrosis in the context of the treatment landscape and its impact on clinical practice. Gaby Hobbs Andrew Kuykendall MD Prithviraj Bose Pankit Vachhani Ashwin Kishtagari, MD #oncology onclive.com/view/majic-pv-…

solid work from the entire team!! 🙏👏 Gaby Hobbs Aaron Gerds MD, MS Lucia Masarova, MD Andrew Kuykendall MD Raajit Rampal, M.D.Ph.D. Ruben A. Mesa, MD Prithviraj Bose and also John Mascarenhas, Abe Yacoub, and Serge Verstovsek.

Great to chat with VJHemOnc about our work on HF in MPNs and AMI outcomes in VWD at this recent ASH! #cardioheme Gaby Hobbs Joan How Dr. Jeffrey Berger JeanConnorsMD Nathan Connell, MD, MPH Lawrence Phillips Glenn Fishman NYU Grossman School of Medicine
vjhemonc.com/video/imzha5_t…

Wonderful international collaboration on the use of splenic irradiation pre-transplant for MF! Thank you Nico Gagelmann for your leadership! onlinelibrary.wiley.com/share/GGBEPC9R…

Moving toward disease modification in polycythemia vera | bLoOd | Dr Jan Bewersdorf & ⁦Raajit Rampal, M.D.Ph.D.⁩ | ⁦Joan How⁩ Naveen Pemmaraju, MD⁩ Mascarenhas ⁦Lucia Masarova, MD⁩ ⁦Prithviraj Bose⁩ || #MPNSM | ⁦Heme Reports⁩ ashpublications.org/blood/article/…

Does improvement in bone marrow fibrosis with JAKi correlate with outcomes in MF? Study by Stephen Oh et al to suggest that there isn't a correlation #mpnsm

onlinelibrary.wiley.com/doi/full/10.10…

There's been exciting progress in #myelofibrosis ! Hear from Gaby Hobbs with Mass General Cancer Center discuss the TRANSFORM-1 trial. She shares how navitoclax + ruxolitinib is showing dramatic spleen volume reduction.

Full article here → tinyurl.com/4meah6vs

#MPNsm #MedTwitter …